Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cnv-2197944 (1 trial)
Neuralgia (Phase 2)
Neuralgia, Postherpetic (Phase 2)
Trials (1 total)
Trial APIs (1 total)